Characterization and chromosomal mapping of a mouse ortholog of the late-infantile ceroid-lipofuscinosis gene CLN2

被引:0
|
作者
Martin L. Katz
Po-Ching Liu
Sarah E. Grob-Nunn
Hisashi Shibuya
Gary S. Johnson
机构
[1] Mason Eye Institute,
[2] University of Missouri School of Medicine,undefined
[3] One Hospital Drive,undefined
[4] Columbia,undefined
[5] Missouri 65212,undefined
[6] USA,undefined
[7] Department of Pathobiology,undefined
[8] College of Veterinary Medicine,undefined
[9] Columbia,undefined
[10] Missouri 65211,undefined
[11] USA,undefined
来源
Mammalian Genome | 1999年 / 10卷
关键词
Codon; Neurodegenerative Disease; Amino Acid Level; Jackson Laboratory; Segregation Analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Late-infantile ceroid-lipofuscinosis (CLN2) is an autosomal recessively inherited, neurodegenerative disease in humans. The CLN2 locus has been mapped to Chromosome (Chr) 11p15, and its sequence and genomic organization have recently been reported. In the present study, the cDNA sequence, exon/intron organization, and chromosomal localization of a mouse ortholog of the CLN2 gene are described. The mouse cDNA contains an open reading frame that predicts a protein product of 562 amino acids. The mouse and human coding regions are 86% and 88% identical at the nucleic acid and amino acid levels, respectively. One less codon appears in the mouse cDNA when compared with the human ortholog. The mouse gene (Cln2) spans more than 6 kb and consists of 13 exons separated by introns ranging in size from 111 to 1259 bp. Length polymorphism in an (AC)n microsatellite in intron 3 of the mouse Cln2 gene was used to perform segregation analysis with The Jackson Laboratory DNA Panel Mapping Resource. On the basis of this analysis, the Cln2 gene was localized to a region of mouse Chr 7 that corresponds to human Chr 11p15. Characterization of the mouse Cln2 gene will facilitate generation of a mouse model for late-infantile ceroid-lipofuscinosis by gene targeting and identification of functionally important regions of the Cln2 protein.
引用
收藏
页码:1050 / 1053
页数:3
相关论文
共 50 条
  • [41] Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
    Dulz, Simon
    Schwering, C.
    Wildner, Jan
    Spartalis, Christoph
    Schuettauf, Frank
    Bartsch, Udo
    Wibbeler, Eva
    Nickel, Miriam
    Spitzer, Martin Stephan
    Atiskova, Yevgeniya
    Schulz, Angela
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022,
  • [42] VALPROIC ACID EXTENDS LIFESPAN OF THE ZEBRAFISH MODEL OF CLN2 DISEASE (LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS)
    Mahmood, Fahad
    Zdebik, Anselm
    Au, Alexandra
    Cooke, Jennifer
    Russell, Claire
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (11):
  • [43] A novel CLN2/TPP1 mutation in a Chinese patient with late infantile neuronal ceroid lipofuscinosis
    Wang, Yu-Liang
    Zeng, Zhi-Yong
    Song, Xing-Wang
    Hao, Zhuo-Fang
    Shi, Yi-Wu
    Tang, Bin
    Chen, Sheng-Qiang
    Gao, Mei-Mei
    Di, Wei
    Long, Yue-Sheng
    Yi, Yong-Hong
    Liao, Wei-Ping
    NEUROGENETICS, 2011, 12 (01) : 93 - 95
  • [44] Characterisation of Late Infantile Neuronal Ceroid Lipofuscinosis gene CLN7
    O'Hare, Megan
    Tuxworth, Richard
    Tear, Guy
    JOURNAL OF NEUROGENETICS, 2010, 24 : 57 - 58
  • [45] Rapid detection of the two most common CLN2 mutations causing classical late infantile neuronal ceroid lipofuscinosis
    Bodzioch, M
    Aslanidis, C
    Kacinski, M
    Zhong, N
    Wisniewski, KE
    Schmitz, G
    CLINICAL CHEMISTRY, 2000, 46 (10) : 1696 - 1699
  • [46] Brain Region-Specific Degeneration with Disease Progression in Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Dyke, J. P.
    Sondhi, D.
    Voss, H. U.
    Yohay, K.
    Hollmann, C.
    Mancenido, D.
    Kaminsky, S. M.
    Heier, L. A.
    Rudser, K. D.
    Kosofsky, B.
    Casey, B. J.
    Crystal, R. G.
    Balton, D.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (06) : 1160 - 1169
  • [47] Characterizing expressive language skills in children with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2): The caregiver perspective
    Phillips, Dawn
    Fernandez, Vivian
    Nevoret, Marie-Laure
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S86 - S86
  • [48] Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis
    Ezaki, J
    Takeda-Ezaki, M
    Oda, K
    Kominami, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (03) : 904 - 908
  • [49] Same gene, surprising difference: adult neuronal ceroid lipofuscinosis linked to CLN6, mutated in variant late-infantile form
    Kay, C.
    CLINICAL GENETICS, 2011, 80 (06) : 505 - U10
  • [50] DNA and enzyme diagnostics for tripeptidyl peptidase I (CLN2) involved in classical late infantile neuronal ceroid lipofuscinosis.
    Franken, PF
    Keulemans, JLM
    Breuning, MH
    Van Diggelen, OP
    Taschner, PEM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A235 - A235